ATE241968T1 - Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren - Google Patents

Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren

Info

Publication number
ATE241968T1
ATE241968T1 AT00961399T AT00961399T ATE241968T1 AT E241968 T1 ATE241968 T1 AT E241968T1 AT 00961399 T AT00961399 T AT 00961399T AT 00961399 T AT00961399 T AT 00961399T AT E241968 T1 ATE241968 T1 AT E241968T1
Authority
AT
Austria
Prior art keywords
sedative
hypnotic
compound
controlled
related methods
Prior art date
Application number
AT00961399T
Other languages
English (en)
Inventor
D Bruce Campbell
W Jay Thiele
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of ATE241968T1 publication Critical patent/ATE241968T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00961399T 1999-08-26 2000-08-28 Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren ATE241968T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38444899A 1999-08-26 1999-08-26
PCT/US2000/023665 WO2001013895A2 (en) 1999-08-26 2000-08-28 Controlled-release sedative-hypnotic compositions and methods related thereto

Publications (1)

Publication Number Publication Date
ATE241968T1 true ATE241968T1 (de) 2003-06-15

Family

ID=23517364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00961399T ATE241968T1 (de) 1999-08-26 2000-08-28 Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren

Country Status (9)

Country Link
EP (2) EP1352647A1 (de)
JP (1) JP2003507413A (de)
AT (1) ATE241968T1 (de)
AU (1) AU7335500A (de)
DE (1) DE60003194T2 (de)
DK (1) DK1206248T3 (de)
ES (1) ES2199857T3 (de)
PT (1) PT1206248E (de)
WO (1) WO2001013895A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
EP1663169A4 (de) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In Antibiotisches produkt, seine verwendung und formulierung
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
EP1970056A1 (de) * 2007-03-15 2008-09-17 Polichem S.A. Zeitspezifische Dosierformen mit verzögerter/pulsatiler Freisetzung
EP2540318B1 (de) 2010-02-22 2018-10-24 Daiichi Sankyo Company, Limited Feststoffpräparat mit verzögerter freisetzung zur oralen verabreichung
JP5714562B2 (ja) * 2010-02-22 2015-05-07 第一三共株式会社 経口用徐放性固形製剤
CN102670613A (zh) * 2011-03-16 2012-09-19 中国人民解放军军事医学科学院毒物药物研究所 用于改善茚地普隆溶出的药物组合物及其制备方法
RU2665372C2 (ru) 2012-09-03 2018-08-29 Дайити Санкио Компани, Лимитед Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
MY177906A (en) * 2014-02-06 2020-09-25 Sequential Medicine Ltd Composition and method for aiding sleep

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
EP1064937A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
US6472528B1 (en) * 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines

Also Published As

Publication number Publication date
WO2001013895A3 (en) 2001-09-27
JP2003507413A (ja) 2003-02-25
ES2199857T3 (es) 2004-03-01
AU7335500A (en) 2001-03-19
PT1206248E (pt) 2003-11-28
DK1206248T3 (da) 2003-09-29
WO2001013895A2 (en) 2001-03-01
DE60003194D1 (de) 2003-07-10
EP1206248A2 (de) 2002-05-22
DE60003194T2 (de) 2004-06-17
EP1206248B1 (de) 2003-06-04
EP1352647A1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
GB9911762D0 (en) Chemical compounds
BR9916835A (pt) Composição de galantamina de liberação controlada
BG106586A (en) Pyrazolopyramidines as therapeutic agents
ES2061204T3 (es) Nuevos derivados de la amino-piperidina, de la amino-pirrolidina y de la amino-perhidroacepina, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NZ508923A (en) N-phenyl-1-Methyl-2-oxo-quinoline-3-carboxamide derivatives, pharmaceuticals thereof and their use in therapy
PA8494101A1 (es) Derivados heterociclicos utiles como agentes anticancerosos
CA2282585A1 (en) Pyrazine compounds
EP1222922A4 (de) Methode zur stabilisierung von benzimidazol-verbindungen
DZ2503A1 (fr) Formulation pure injectable d'un composé anesthésique.
PT1206248E (pt) Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos
MX9605458A (es) Derivados de amida y su uso terapeutico.
BRPI9916820A2 (pt) Formulações farmacêuticas
EP0913151A4 (de) Anti-helicobacter pylori zusammensetzungen die 1-methylcarbapenem-derivate als wirkstoffe enthalten
TW336929B (en) Benzenesulphonamide derivatives, their preparation and their application in therapy
EP1061070A4 (de) 24-hydroxy-vitamin-d-derivate
HUT54169A (en) Process for producing p-substituted propanephosphinic acid derivatives and pharmaceutical compositions comprising same as active ingredient
DE59108026D1 (de) Phenylalkylaminoalkyl-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
GB2402335B (en) Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1,5-bipyridazine in nanoparticulate form
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE68909961D1 (de) 2-Aminoacetamid Derivate.
IL110369A0 (en) Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206248

Country of ref document: EP

REN Ceased due to non-payment of the annual fee